Company profile
Opus Genetics, Inc. Insider Trading
IRDEvery SEC Form 4 insider trading filing for Opus Genetics, Inc. (IRD) since April 2023: open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Exchange
- Nasdaq
- Sector
- Pharmaceutical Preparations
- CIK
- 0001228627
- Filings
- 115
- Insiders
- 19
- Last filing
- 2026-09-09
Activity summary
No discretionary insider buying or selling in the last 30 days. Of the 6 transactions filed, 1 was scheduled under a 10b5-1 plan and 5 were grants, option exercises or other non-open-market activity.
Three year balance
Buy and sell value by quarter, Q4 23 to Q3 26. Opus Genetics, Inc. insiders are net sellers across the period shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $8.7M.
90 day insight
Over the last 90 days, Opus Genetics, Inc. insiders sold $87K across 4 transactions with no open-market purchases.
- Most active insider: George Magrath with 4 transactions totaling $930K.
- Largest single sale: $127K by Robert E. Gagnon on Sep 3, 2026.
- 20% of recent sales were pre-scheduled 10b5-1 trades, typically less informative than open-market activity.
Activity skews bearish: sales outpace buys.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 9, 2026 | George Magrath | IRD | Option Exercise | 392,157 | $1.15 | $451K |
| Sep 9, 2026 | George Magrath | IRD | Tax Withholding | 75,541 | $5.97 | $451K |
| Sep 9, 2026 | George Magrath | IRD | Option Exercise | 392,157 | — | — |
| Sep 8, 2026 | Cam Gallagher | IRD | Option Exercise | 784,314 | $1.15 | $902K |
| Sep 8, 2026 | Cam Gallagher | IRD | Option Exercise | 784,314 | — | — |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=IRD" \
-H "X-Api-Key: $KEY"Top insiders
By open-market value traded.
Institutional Ownership
Top 13F-HR holders of Opus Genetics, Inc. as of 2026-06-30
Data source: quarterly 13F-HR filings: institutional holders report positions within 45 days of quarter end. Joined with insider activity above: see who's loading up institutionally while insiders are trading. Full 13F-HR API →